Statistics

Total Visits

Views
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial83

File Visits

Downloads
35923-233.pdf25

Select a period of time:

Number of views in the range

Views
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial49

Number of downloads in the range

Downloads
35923-233.pdf7

Views

Views
February 20250
March 202516
April 202513
May 20255
June 20253
July 202511
August 20251
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • February 2025
    2
  • March 2025
    0
  • April 2025
    2
  • May 2025
    0
  • June 2025
    0
  • July 2025
    1
  • August 2025
    2
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
Hong Kong11
United States8
Brazil6
Germany2
Austria2
Ecuador1
United Kingdom1
Mexico1
 

Top countries by downloads

Downloads
United States4
Hong Kong2
Mexico1
 

Top cities views

Views
Hong Kong11
Nuremberg2
Columbus2
Ananindeua1
Charlotte1
Council Bluffs1
Cramlington1
Dallas1
Feliz1
Largo1
 

Top cities by downloads

Downloads
Hong Kong2